PT Wahana Pronatural Tbk (IDX:WAPO)

Indonesia flag Indonesia · Delayed Price · Currency is IDR
141.00
-3.00 (-2.08%)
Aug 1, 2025, 3:49 PM WIB

Intra-Cellular Therapies Cash Flow Statement

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Net Income
-3,152718.93218.57-4,067-1,597-1,465
Upgrade
Depreciation & Amortization
1,8021,7761,5252,1482,9512,850
Upgrade
Other Operating Activities
-2,512936.277,889187.04-2,459-712.75
Upgrade
Operating Cash Flow
-3,8633,4319,633-1,731-1,106672.48
Upgrade
Operating Cash Flow Growth
--64.38%----43.34%
Upgrade
Capital Expenditures
6,259-2,332-2,945---
Upgrade
Sale of Property, Plant & Equipment
----28.5-
Upgrade
Investing Cash Flow
6,259-2,332-2,945-28.5-
Upgrade
Net Cash Flow
2,3961,0996,688-1,731-1,077672.48
Upgrade
Free Cash Flow
2,3961,0996,688-1,731-1,106672.48
Upgrade
Free Cash Flow Growth
-4.39%-83.57%----43.34%
Upgrade
Free Cash Flow Margin
0.13%0.05%1.59%-0.53%-0.35%0.30%
Upgrade
Free Cash Flow Per Share
1.930.975.83-1.39-0.870.54
Upgrade
Cash Income Tax Paid
3,1364,586945.22671.13289.92324.78
Upgrade
Levered Free Cash Flow
1,094-758.956,426-815.6-1,243209.7
Upgrade
Unlevered Free Cash Flow
1,094-758.956,426-815.6-1,243209.7
Upgrade
Change in Net Working Capital
3,953527-8,070-759.391,916780.46
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.